Heidi H Kong

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Skin microbiome: genomics-based insights into the diversity and role of skin microbes
    Heidi H Kong
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, Bldg 10, Rm 12N238, Bethesda, MD 20892, USA
    Trends Mol Med 17:320-8. 2011
  2. pmc Cutaneous pigmentation after photosensitivity induced by vandetanib therapy
    Heidi H Kong
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bldg 10, Room 12N238, 10 Center Dr, Bethesda, MD 20892, USA
    Arch Dermatol 145:923-5. 2009
  3. pmc Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction
    Lokesh Jain
    Clinical Pharmacology Program, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Pharmacotherapy 30:52-6. 2010
  4. pmc The altered landscape of the human skin microbiome in patients with primary immunodeficiencies
    Julia Oh
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland 20892, USA
    Genome Res 23:2103-14. 2013
  5. pmc Topographic diversity of fungal and bacterial communities in human skin
    Keisha Findley
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Nature 498:367-70. 2013
  6. pmc Topographical and temporal diversity of the human skin microbiome
    Elizabeth A Grice
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda, MD 20892, USA
    Science 324:1190-2. 2009
  7. pmc Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
    Heidi H Kong
    Dermatology Branch, Center for Cancer Research, National Cancer Institute NIH, Bethesda, MD 20892, USA
    Genome Res 22:850-9. 2012
  8. pmc Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy
    Nilofer S Azad
    Medical Oncology Branch, Biostatistics and Data Management Section, Center for Cancer Research, NIH, Bethesda, Maryland 20892, USA
    Clin Cancer Res 15:1411-6. 2009
  9. pmc Skin microbiome: looking back to move forward
    Heidi H Kong
    Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Invest Dermatol 132:933-9. 2012
  10. pmc A diversity profile of the human skin microbiota
    Elizabeth A Grice
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Genome Res 18:1043-50. 2008

Collaborators

Detail Information

Publications10

  1. pmc Skin microbiome: genomics-based insights into the diversity and role of skin microbes
    Heidi H Kong
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, Bldg 10, Rm 12N238, Bethesda, MD 20892, USA
    Trends Mol Med 17:320-8. 2011
    ..This review discusses current skin microbiome research, with a primary focus on bacteria, and the challenges facing investigators striving to understand how skin microorganisms contribute to health and disease...
  2. pmc Cutaneous pigmentation after photosensitivity induced by vandetanib therapy
    Heidi H Kong
    Dermatology Branch, Center for Cancer Research, National Cancer Institute, Bldg 10, Room 12N238, 10 Center Dr, Bethesda, MD 20892, USA
    Arch Dermatol 145:923-5. 2009
    ..Photosensitivity has been reported in patients who were treated with vandetanib (ZD6474), an inhibitor of epidermal growth factor receptor, vascular endothelial growth factor receptor, and the RET (rearranged during transfection) kinases...
  3. pmc Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction
    Lokesh Jain
    Clinical Pharmacology Program, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland 20892, USA
    Pharmacotherapy 30:52-6. 2010
    ..To determine if excretion of sorafenib in sweat is associated with hand-foot skin reaction in patients receiving sorafenib...
  4. pmc The altered landscape of the human skin microbiome in patients with primary immunodeficiencies
    Julia Oh
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, NIH, Bethesda, Maryland 20892, USA
    Genome Res 23:2103-14. 2013
    ....
  5. pmc Topographic diversity of fungal and bacterial communities in human skin
    Keisha Findley
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Nature 498:367-70. 2013
    ..These results provide a framework for future investigation of the contribution of interactions between pathogenic and commensal fungal and bacterial communities to the maintainenace of human health and to disease pathogenesis...
  6. pmc Topographical and temporal diversity of the human skin microbiome
    Elizabeth A Grice
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, Bethesda, MD 20892, USA
    Science 324:1190-2. 2009
    ..This topographical and temporal survey provides a baseline for studies that examine the role of bacterial communities in disease states and the microbial interdependencies required to maintain healthy skin...
  7. pmc Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis
    Heidi H Kong
    Dermatology Branch, Center for Cancer Research, National Cancer Institute NIH, Bethesda, MD 20892, USA
    Genome Res 22:850-9. 2012
    ....
  8. pmc Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy
    Nilofer S Azad
    Medical Oncology Branch, Biostatistics and Data Management Section, Center for Cancer Research, NIH, Bethesda, Maryland 20892, USA
    Clin Cancer Res 15:1411-6. 2009
    ..We retrospectively analyzed dermatologic toxicity in patients receiving combined antiangiogenic therapy involving sorafenib and bevacizumab...
  9. pmc Skin microbiome: looking back to move forward
    Heidi H Kong
    Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Invest Dermatol 132:933-9. 2012
    ..Herein, we explore the history of this field, describe findings from the current molecular sequencing era, and consider the future of investigating how microbes and antimicrobial therapy contribute to human health...
  10. pmc A diversity profile of the human skin microbiota
    Elizabeth A Grice
    Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Genome Res 18:1043-50. 2008
    ....